The chemical switch that controls your skin's color and vision

Health · Published 18 October 2026 Swipe more like this →

In short: Tyrosinase is the master architect of pigment. By converting a simple amino acid into dopaquinone, this enzyme dictates the color of your hair, skin, and eyes. When this process goes wrong, it can cause severe skin diseases—or, if completely silenced, lead to profound visual impairment.

Tyrosinase is a copper-containing enzyme encoded by the TYR gene. It is primarily located in melanocytes, where it performs the rate-limiting first step of melanin production. By hydroxylating monophenols and oxidizing o-diphenols, it creates the precursors for the pigments that color human hair, skin, and the iris. Beyond aesthetics, tyrosinase is vital for vision; it produces melanin in the retina, where it plays a critical role in normal sight.

Genetic mutations in the TYR gene can disrupt this delicate balance. In humans, over 100 mutations have been identified that cause oculocutaneous albinism type 1. Some mutations completely eliminate tyrosinase activity (type 1A), resulting in white hair, pale skin, and vision problems. Other mutations merely reduce its activity (type 1B), allowing for some pigment production that may darken over time.

Because of its role in pigment, tyrosinase is a major target for the pharmaceutical and cosmetic industries. Inhibitors are used to treat hyperpigmentation, whiten skin, and prevent fruit browning. However, the chemistry is complex. For example, hydroquinone (HQ) is a controversial whitening agent; while it can inhibit tyrosinase, it can also act as a substrate, potentially generating reactive oxygen species that cause permanent loss of melanocytes. In contrast, tea catechins like epigallocatechin (EGC) have shown potential as natural, reversible inhibitors by changing the enzyme's conformation.

The enzyme's active site features a binuclear, type 3 copper center coordinated by histidine residues. This center interacts with molecular oxygen to form a reactive intermediate. Understanding these specific binding mechanisms—such as how kojic acid acts as a mixed inhibitor versus how HQ behaves differently depending on the presence of L-dopa—is essential for developing safer, more effective treatments for skin disorders.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• The complex biological pathways that govern how our bodies produce melanin
• Why your hair color is more than just a simple pigment ratio
• Every human skin tone mixes its two main pigments in nearly the same ratio
• Albinism is not a disease, but a genetic variation in how bodies produce pigment.
• Why do some people develop white patches on their skin that never go away?
• Why giving your body just a piece of a virus works
• Is Omicron a different serotype? The case for viral 'jumps'
• A maternal vaccine that creates a shield for the unborn
• The 1954 test of the polio vaccine involved 1.8 million children.
• The laboratory of hygiene that shaped modern immunology
• The precise angle where light loses its ability to reflect
• Training the immune system to hunt cancer cells without harming healthy tissue

More in Vaccines · More in Health · Latest · A–Z · All topics